| # | Drug | Count |
|---|---|---|
| 0 | BEVACIZUMAB | 37 |
| 1 | OXALIPLATIN | 27 |
| 2 | FUROSEMIDE | 24 |
| 3 | ATEZOLIZUMAB | 21 |
| 4 | FLUOROURACIL | 20 |
| 5 | FLUOROURACIL CREAM, 0.5% | 20 |
| 6 | RIBAVIRIN | 20 |
| 7 | SPIRONOLACTONE | 20 |
| 8 | LANSOPRAZOLE | 16 |
| 9 | ASPIRIN | 14 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | HYDROCORTISONE CREAM 1% WITH ALOE | 1 | 0.0286 |
| 1 | HYDROCORTISONE CREAM 0.5% WITH ALOE | 1 | 0.0286 |
| 2 | LORATADINE 10 MG | 1 | 0.0222 |
| 3 | TERLIPRESSIN | 1 | 0.0030 |
| 4 | CORTISOL | 1 | 0.0025 |
| 5 | ADENOSINE | 2 | 0.0012 |
| 6 | PEMIGATINIB | 1 | 0.0012 |
| 7 | NITISINONE | 1 | 0.0010 |
| 8 | LEVOLEUCOVORIN INJECTION | 3 | 0.0010 |
| 9 | ELRANATAMAB-BCMM | 1 | 0.0009 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Vasopressin Receptor Agonist [EPC] | 1 | 0.0030 |
| 1 | 4-Hydroxyphenyl-Pyruvate Dioxygenase Inhibitor [EPC] | 1 | 0.0012 |
| 2 | Thyroid Hormone Receptor beta Agonist [EPC] | 1 | 0.0004 |
| 3 | Hepatitis C Virus Nucleotide Analog NS5B Polymerase Inhibitor [EPC] | 22 | 0.0004 |
| 4 | Adenosine Receptor Agonist [EPC] | 2 | 0.0003 |
| 5 | Anti-coagulant [EPC] | 1 | 0.0003 |
| 6 | Photoenhancer [EPC] | 1 | 0.0003 |
| 7 | Programmed Death Receptor-1 Blocking Antibody [EPC] | 25 | 0.0003 |
| 8 | Provitamin D2 Compound [EPC] | 7 | 0.0002 |
| 9 | Nucleoside Analog Antiviral [EPC] | 20 | 0.0002 |